News Archives - Page 1139 of 1149 - BioHealth Innovation

News

InvestMaryland VC firms to be recommended by London’s Altius Associates – Baltimore Business Journal

Maryland has chosen a London firm to oversee the selection of venture capital firms interested in making investments in young…

Super UserApril 5, 2012

News

NIH and Lilly Collaborate, Aim to Make Drug Development Pipelines More Productive | Highlight HEALTH

Over the past decade, collaborative research efforts to support the discovery and development of medicines has increased dramatically. Last month,…

Super UserApril 5, 2012

News

MedImmune central to AstraZeneca-Amgen antibody deal – Washington Business Journal

Pharmaceutical giants AstraZeneca PLC and Amgen Inc. just announced a deal to co-develop and co-commercialize five product candidates, all monoclonal…

Super UserApril 5, 2012

News

Biotech Can’t Sidestep Cost-Effectiveness Anymore | Xconomy

Back in the old days of biotech, the business was pretty straightforward. You’d craft your scientific idea, aim a new drug…

Super UserApril 5, 2012

News

What venture capitalists look for in personalized medicine investments

Companies like Starbucks (NASDAQ:SBUX), Amazon.com (NASDAQ:AMZN) and Apple (NASDAQ:AAPL) aren’t healthcare companies, but one venture capitalist believes their example can…

Super UserApril 5, 2012

News

Gene mapping isn’t a crystal ball for future health… yet – NY Daily News

Gene scans for everyone? Not so fast. New research suggests that for the average person, decoding your own DNA may…

Super UserApril 3, 2012

News

Emergent’s Fuad El-Hibri, an entrepreneur at heart

Fuad El-Hibri has started a financial consulting business. He’s started telecommunications businesses. But his most challenging venture has been the…

Super UserApril 3, 2012

News

UNH Center for Venture Research: U.S. Angel Investor Market on Solid Path of Recovery in 2011

Following a considerable contraction in investment dollars in 2008 and 2009, the U.S. angel investor market continued to recover in…

Super UserApril 3, 2012

News

AstraZeneca links up with Amgen for treatments development

Shares in AstraZeneca ticked up after the Anglo-Swedish drugs giant announced a tie-up with biotechnology giant Amgen to develop and…

Super UserApril 3, 2012

News

Big Pharma Cozies Up to Biotech – DailyFinance

Pharmaceuticals have figured that out that if they can't be as innovative or nimble as biotechs, the next best option…

Super UserMarch 31, 2012

Previous 1 … 1,137 1,138 1,139 1,140 1,141 … 1,149 Next

News

InvestMaryland VC firms to be recommended by London’s Altius Associates – Baltimore Business Journal

NIH and Lilly Collaborate, Aim to Make Drug Development Pipelines More Productive | Highlight HEALTH

MedImmune central to AstraZeneca-Amgen antibody deal – Washington Business Journal

Biotech Can’t Sidestep Cost-Effectiveness Anymore | Xconomy

What venture capitalists look for in personalized medicine investments

Gene mapping isn’t a crystal ball for future health… yet – NY Daily News

Emergent’s Fuad El-Hibri, an entrepreneur at heart

UNH Center for Venture Research: U.S. Angel Investor Market on Solid Path of Recovery in 2011

AstraZeneca links up with Amgen for treatments development

Big Pharma Cozies Up to Biotech – DailyFinance

About BioHealth Innovation

Contact

Connect